Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001186120-05-000018
Filing Date
2005-03-21
Accepted
2005-03-21 14:59:20
Documents
2
Period of Report
2005-03-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 6239
2 EDGAR SUPPORTING DOCUMENT silverstein.txt EX-24 735
  Complete submission text file 0001186120-05-000018.txt   9035
Mailing Address 11388 SORRENTO VALLEY ROAD SUITE 200 SAN DIEGO CA 92121
Business Address 11388 SORRENTO VALLEY ROAD STE 200 SAN DIEGO CA 92121 8586225200
AVANIR PHARMACEUTICALS (Issuer) CIK: 0000858803 (see all company filings)

EIN.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 2127396400
SILVERSTEIN JONATHAN (Reporting) CIK: 0001171005 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15803 | Film No.: 05694013